Lexaria Bioscience Corp. (LXRP)

Other OTC - Other OTC Delayed Price. Currency in USD

Add to watchlist

0.2249-0.0269 (-10.68%)

At close: 3:59PM EST

Major Holders

Insider Roster

Insider Transactions

Currency in USD

Insider Purchases Last 6 Months	Shares	Trans
Purchases	N/A	N/A
Sales	N/A	N/A
Net Shares Purchased (Sold)	N/A	N/A
Total Insider Shares Held	N/A	N/A
% Net Shares Purchased (Sold)	N/A	N/A

Net Institutional Purchases Prior Quarter to Latest Quarter	Shares
Net Shares Purchased (Sold)	N/A
% Change in Institutional Shares Held	N/A

Insider Transactions Reported - Last Two Years

Insider	Transaction	Type	Value	Date	Shares
MCKECHNIE WILLIAM EDWARD Director	Conversion of Exercise of derivative security at price 0.17 per share.	Direct	19,030	Jul. 23, 2020	110,000
BUNKA CHRISTOPHER ANDREW Chief Executive Officer	Stock Award(Grant) at price 0.23 per share.	Indirect	46,000	May 06, 2020	200,000
BAXTER NICHOLAS W Director	Conversion of Exercise of derivative security at price 0.10 per share.	Direct	11,000	Dec. 20, 2019	110,000
SPISSINGER ALLAN HORST Chief Financial Officer	Conversion of Exercise of derivative security at price 0.37 per share.	Direct	18,500	Feb. 15, 2019	50,000
BUNKA CHRISTOPHER ANDREW Chief Executive Officer	Stock Award(Grant) at price 2.07 per share.	Direct	67,275	Aug. 31, 2018	32,500
DOCHERTY JOHN MARTIN President	Stock Award(Grant) at price 2.07 per share.	Indirect	75,555	Aug. 31, 2018	36,500
BUNKA CHRISTOPHER ANDREW Chief Executive Officer	Stock Gift at price 0.00 per share.	Direct	0	Aug. 14, 2018	500,000
BUNKA CHRISTOPHER ANDREW Officer, Director and Beneficial Owner	Stock Award(Grant) at price 1.78 per share.	Direct	144,625	Aug. 03, 2018	81,250
DOCHERTY JOHN MARTIN Director and Beneficial Owner of more than 10% of a Class of Security	Stock Award(Grant) at price 1.78 per share.	Indirect	487,275	Aug. 03, 2018	273,750
BUNKA CHRISTOPHER ANDREW Chief Executive Officer	Conversion of Exercise of derivative security at price 0.09 - 0.14 per share.	Indirect	85,275	Jun. 18, 2018	697,500
MCKECHNIE WILLIAM EDWARD Director	Sale at price 1.52 per share.	Direct	76,000	May 31, 2018	50,000
BUNKA CHRISTOPHER ANDREW Chief Executive Officer	Stock Award(Grant) at price 0.82 per share.	Direct	24,170	Dec. 01, 2017	29,475
DOCHERTY JOHN MARTIN Director and Beneficial Owner of more than 10% of a Class of Security	Stock Award(Grant) at price 0.82 per share.	Indirect	28,700	Dec. 01, 2017	35,000
MCKECHNIE WILLIAM EDWARD Director	Stock Award(Grant) at price 0.82 per share.	Direct	12,000	Dec. 01, 2017	14,634
SPISSINGER ALLAN HORST Chief Financial Officer	Stock Award(Grant) at price 0.82 per share.	Direct	34,166	Dec. 01, 2017	41,666
MCKECHNIE WILLIAM EDWARD Director	Stock Award(Grant) at price 0.37 per share.	Direct	12,000	Aug. 28, 2017	32,433
DOCHERTY JOHN MARTIN President	Stock Award(Grant) at price 0.29 per share.	Indirect	61,950	Jun. 22, 2017	210,000
BUNKA CHRISTOPHER ANDREW Chief Executive Officer	Stock Award(Grant) at price 0.29 per share.	Indirect	61,950	Jun. 21, 2017	210,000
MCKECHNIE WILLIAM EDWARD Director	Stock Award(Grant) at price 0.34 per share.	Direct	11,985	May 31, 2017	35,249
MCKECHNIE WILLIAM EDWARD Director	Stock Award(Grant) at price 0.34 per share.	Direct	12,000	May 31, 2017	35,294
DOCHERTY JOHN MARTIN President	Stock Award(Grant) at price 0.14 per share.	Indirect	35,280	Oct. 11, 2016	252,000
MCKECHNIE WILLIAM EDWARD Director	Stock Award(Grant) at price 0.14 per share.	Direct	16,000	Oct. 11, 2016	114,286
BUNKA CHRISTOPHER ANDREW Chief Executive Officer	Stock Award(Grant) at price 0.00 per share.	Indirect	0	Dec. 16, 2015	1,073,834
BAXTER NICHOLAS W Director	Stock Award(Grant) at price 0.00 per share.	Direct	0	Dec. 16, 2015	20,000
BHULLAR BALJINDER Chief Financial Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	Dec. 16, 2015	14,125
DOCHERTY JOHN MARTIN President	Stock Award(Grant) at price 0.00 per share.	Indirect	0	Dec. 16, 2015	55,000
MCKECHNIE WILLIAM EDWARD Director	Stock Award(Grant) at price 0.00 per share.	Direct	0	Dec. 16, 2015	10,000
BUNKA CHRISTOPHER ANDREW Chief Executive Officer	Conversion of Exercise of derivative security at price 0.20 per share.	Direct	20,000	Jul. 15, 2011	100,000
DEMARTINI DAVID Director and Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 0.20 per share.	Direct	300,000	Jun. 08, 2011	1,500,000
DEMARTINI DAVID Director	Conversion of Exercise of derivative security at price 0.20 per share.	Direct	21,250	Mar. 18, 2011	106,250
IHRKE THOMAS JAMES Officer	Sale at price 0.35 per share.	Direct	245	Dec. 22, 2010	700
DEMARTINI DAVID Director	Conversion of Exercise of derivative security at price 0.22 per share.	Direct	11,000	Dec. 13, 2010	50,000

S&P/TSX17,909.03-49.07(-0.27%)

S&P 5003,768.25-27.29(-0.72%)

DOW30,814.26-177.24(-0.57%)

Lexaria Bioscience Corp. (LXRP)

Insider Transactions

Insider Transactions Reported - Last Two Years

S&P/TSX
17,909.03
-49.07(-0.27%)

S&P 500
3,768.25
-27.29(-0.72%)

DOW
30,814.26
-177.24(-0.57%)